Global Marketing Director, ETASi (CVRM)

Gaithersburg, MD (On-site)

$229K/yr – $344K/yrDirector/Executive10+ years expFull time

Posted 2 months ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Drive global CVRM marketing strategy from Phase 3 through launch, aligning with disease-area plans and cross-functional teams.

  • Must-have: 10+ years of biopharma commercial/strategic marketing with specialist launch experience.
  • Standout: Global CVRM launch experience across markets with cross-functional and agency collaboration.
  • Standout: AI/digital-enabled strategy and operational excellence expertise.

Job Description

Responsibilities

  • Develop Commercial strategy and planning: Drive success across indications from Phase 3 through to launch and Shape product strategy with a tie to disease area strategies and insights in CKD in close collaboration with other Global Brand Directors and Cross Functional team members
  • Generate & use customer insights (patient, physician, payer) to inform clinical development and to create differentiated and winning brand strategies and support with objectively analyzing and commercially evaluating competitive positioning, unmet need, etc.
  • Contribute to the business LTP and MTP business planning cycle. Support the development of evidence-based forecasts that are aligned with the target product profile and that credibly reflect a range of commercial potential
  • Engage and collaborate with internal and external customers. Work in collaboration with markets to develop commercial programs to drive and address barriers to adoption at launch. Manage marketing relationships with agencies, vendor partners, consultants, and other third-party groups . Collaborate with CVRM Commercial leadership (and other team members) to deliver the global CVRM ambition, including successful product launch plans.
  • Ways of working and reporting line: Comply with AZ policies, standards and procedures in every interaction. The role reports to the Global Head of Marketing, ETASi asset

Requirements

  • Bachelor’s degree; MBA or advanced degree preferred.
  • 10+ years of commercial or strategic marketing experience in biopharma.
  • Specialist launch experience in a competitive space
  • Experience leveraging clinical data to shape brand strategies and lifecycle planning
  • Strong working knowledge of forecasting, market research, useful insight generation, and competitive landscape analysis and interpretation.
  • Demonstrated experience in insight generation, positioning, and market shaping.
  • Experience from leveraging AI and digital to drive commercial strategy and operational excellence.

Preferred

  • An advanced degree (MBA, MSc or PhD) is preferred
  • Deep CVRM expertise
  • US specialists launch experience
  • Working across geographies and cultures
  • Launch experience in multiple global markets

Benefits

  • Benefits offered included a qualified retirement program [401(k) plan]; paid vacation and holidays; paid leaves; and, health benefits including medical, prescription drug, dental, and vision coverage in accordance with the terms and conditions of the applicable plans.
AstraZeneca logo

AstraZeneca

4.0 Glassdoor

We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com.Community Guidelines: bit.ly/2MgAcio

Founded in 1999
Cambridge, England, GBR
77K employees (4,201 in marketing)
78% recommend to a friend
89% CEO approval

Traffic Signals

Monthly Visitors
1.3M
Monthly Google Ads Budget
$3.7K
Traffic Source Mix
Search
45.1%
Direct
42%
Referral
9.3%
Social
2.6%
Paid
0.9%

Headcount Trend

Current headcount: ~76.8K

Marketing Team

Marketing Team Size
3,642 (5% of company)
Median Career Experience
15 years
Median Tenure
5.3 years
Marketing Roles Posted (Last 30 Days)
18

Funding

Total Funding
$7.3B
Last Raise
$2B
Post IPO Debt, 19 days ago

Funding History

  • Feb 2026
    Post IPO Debt • $2B
  • Jul 2024
    Post IPO Debt • $1.5B
  • Feb 2023
    Post IPO Debt • $2.3B

Recent News